Patients with chronic lung disease are at risk for severe complications of COVID-19. As such, there is a need to better understand how to protect this population. This program reviews the impact of COVID-19 in people with lung disease and other respiratory problems, and provides recommendations to optimize care.
Note: This expert brief was recorded on May 9th, 2023.
This program has received funding from Moderna Biopharm Canada Inc.